Compounded semaglutide and tirzepatide now cost less at lower starting doses, and members can order cholesterol, A1C and thyroid panels in the same app.
Recap by typeshit. Full story at Statesman Journal.
Early trial results suggest the shot could one day help people hold onto weight loss after they come off GLP-1 drugs.
The telehealth company is also adding blood testing services alongside the lower costs for its compounded GLP-1 options.
Huberman says verified, US-made sourcing would change the peptide market, and wonders which compounds beyond GLPs would qualify.
A general explainer on why the body holds onto its large fat reserves even though they carry tens of thousands of calories.
The CHMP opinion from 15 October now goes to the European Commission. In trials, people on the daily orforglipron tablet lost about 5% to 11% of body weight over 72 weeks.
Dr David Barzilai traced the development records of popular compounds and found many trace back to pharmaceutical companies.
Loading…